SBIR/STTR Research Award
Amotosalen PCT of Leukapheresis Units for GvHD Therapy
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CERUS CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- KJJQRRLY2FL5
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): This is a combined Phase I/II SBIR Fast-Track proposal. Bone marrow transplantation has the potential of providing a complete cure of the disease symptoms of hematologic malignancies and, ultimately, with an appropriat
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Vaccine-enhanced DLI to prevent cancer recurrence after stem cell transplantation
- Listeria-Based Ovarian Cancer Polyepitope Vaccines
- Listeria Immunotherapy for Pancreatic and Ovarian Cancer
- Listeria-CEA Vaccine-Infected DC for Cancer Therapy
- MINIATURIZED INSTRUMENTATION FOR THE HTS OF DNA REPAIR
Research funding history
13 SBIR/STTR records share this UEI (2003–2006). Reported award amounts total $3,435,972. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services